Official start of project LEGATO

The European Organisation for Research and Treatment of Cancer (EORTC) and the Syreon Research Institute are delighted to announce the official start of LEGATO, a pragmatic phase III clinical trial focusing on recurrent Glioblastoma. This is the first official trial looking into the potential benefits of chemo-irradiation compared to chemotherapy alone to improve disease control […]